Spero Therapeutics Income Statement (2016-2025) | SPRO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.10M-0.07M0.14M0.25M0.60M0.99M0.46M0.66M1.69M7.72M2.16M4.64M0.70M1.70M1.73M4.00M1.91M7.30M5.15M3.06M2.74M2.07M1.99M2.01M12.93M2.07M2.72M25.47M73.52M9.27M10.20M13.47M15.04M5.87M14.19M5.44M
Operating items
Research & Development 6.00M6.93M6.00M7.46M6.91M12.50M8.93M7.37M8.46M9.13M9.53M12.03M18.50M25.73M20.44M15.66M17.71M13.21M18.40M14.46M14.44M17.23M16.97M8.17M7.36M15.09M8.98M9.51M16.39M16.56M17.33M23.73M26.86M28.84M13.61M10.67M8.60M
Selling, General & Administrative 1.91M2.22M1.74M2.96M3.65M2.49M3.04M3.06M3.13M3.65M3.89M3.78M4.13M3.79M4.09M4.55M5.31M7.50M8.30M9.23M11.15M13.02M15.30M8.05M6.63M6.50M7.32M6.10M5.71M6.43M5.92M5.53M5.20M7.06M6.82M5.88M4.17M
Restructuring Costs 11.85M-0.15M-0.07M0.88M0.17M0.08M
Other Operating Expenses 5.31M0.59M
Operating Expenses 7.91M9.14M7.74M10.41M10.56M14.99M11.97M10.43M11.59M12.78M13.41M15.81M22.63M29.51M24.52M20.20M23.02M20.70M26.70M23.69M25.59M30.25M32.28M28.07M13.84M21.52M16.30M15.61M27.41M22.99M23.25M29.26M32.06M36.77M20.61M16.63M13.36M
Operating Income -7.91M-8.81M-7.60M-10.16M-9.97M-14.00M-10.82M-9.97M-10.94M-11.08M-5.70M-13.65M-17.98M-25.88M-22.82M-18.48M-19.02M-18.80M-19.40M-18.54M-22.52M-27.50M-30.21M-26.08M-11.83M26.77M-14.23M-12.89M-1.93M54.45M-13.98M-19.06M-18.59M-21.73M-14.73M-2.44M-7.92M
EBIT -7.91M-8.81M-7.60M-10.16M-9.97M-14.00M-10.82M-9.97M-10.94M-11.08M-5.70M-13.65M-17.98M-25.88M-22.82M-18.48M-19.02M-18.80M-19.40M-18.54M-22.52M-27.50M-30.21M-26.08M-11.83M26.77M-14.23M-12.89M-1.93M54.45M-13.98M-19.06M-18.59M-21.73M-14.73M-2.44M-7.92M
Non-operating items
Interest & Investment Income -0.01M0.05M0.12M0.14M0.17M0.01M0.47M0.44M0.24M0.37M0.40M0.32M0.24M0.09M0.03M0.05M0.10M0.08M0.09M0.08M0.07M0.11M0.21M0.71M0.96M0.98M0.95M1.04M1.33M1.20M1.18M1.03M0.86M0.74M0.53M
Other Non Operating Income -0.00M0.61M1.19M0.40M0.12M0.13M0.17M0.01M0.47M-0.62M0.39M0.14M-0.14M0.35M-0.67M0.89M0.06M0.16M-0.12M-0.11M-0.09M-0.08M-0.19M0.99M-0.03M0.14M-0.00M-0.01M-0.01M0.00M-0.01M0.00M-0.03M0.10M0.00M0.00M0.00M
Non Operating Income -0.00M0.61M1.19M0.40M0.12M0.13M0.17M0.01M0.47M0.48M0.62M0.50M0.27M0.90M-0.67M0.97M0.08M0.21M-0.12M-0.11M-0.09M-1.47M-2.62M-2.60M0.16M0.85M0.96M0.98M0.94M1.05M1.31M1.20M1.16M1.13M0.86M0.74M0.53M
Net income details
EBT -7.91M-8.81M-7.61M-10.11M-9.84M-13.86M-10.64M-9.96M-10.46M-10.64M-5.46M-13.29M-17.58M-25.56M-22.58M-18.39M-18.99M-18.75M-19.30M-18.46M-22.43M-27.43M-30.14M-25.97M-11.63M27.49M-13.26M-11.91M-0.98M55.50M-12.65M-17.86M-17.41M-20.70M-13.87M-1.70M-7.38M
Tax Provisions 2.21M0.39M0.29M-0.29M
Profit After Tax -7.92M-8.20M-6.41M-9.76M-9.84M-13.87M-10.64M-9.96M-10.46M-10.60M-5.07M-13.15M-17.72M-24.99M-23.26M-17.50M-18.94M-18.59M-19.42M-18.57M-22.52M-29.28M-32.83M-28.68M-11.68M26.77M-13.27M-11.91M-3.21M51.21M-12.70M-17.90M-17.15M-20.90M-13.90M-1.70M-7.40M
Income from Non-Controlling Interests -1.60M-0.99M-0.54M-0.59M-0.01M-0.01M
Income from Continuing Operations -7.91M-8.81M-7.61M-10.11M-9.84M-13.86M-10.64M-9.96M-10.46M-10.64M-5.46M-13.29M-17.58M-25.56M-22.58M-18.39M-18.99M-18.75M-19.30M-18.46M-22.43M-27.43M-30.14M-25.97M-11.63M27.49M-13.26M-11.91M-3.19M55.11M-12.65M-17.86M-17.70M-20.41M-13.87M-1.70M-7.38M
Consolidated Net Income -7.91M-8.81M-7.61M-10.11M-9.84M-13.86M-10.64M-9.96M-10.46M-10.64M-5.46M-13.29M-17.58M-25.56M-22.58M-18.39M-18.99M-18.75M-19.30M-18.46M-22.43M-27.43M-30.14M-25.97M-11.63M27.49M-13.26M-11.91M-3.19M55.11M-12.65M-17.86M-17.70M-20.41M-13.87M-1.70M-7.38M
Income towards Parent Company -7.91M-8.81M-7.61M-10.11M-9.84M-13.86M-10.64M-9.96M-10.46M-10.64M-5.46M-13.29M-17.58M-25.56M-22.58M-18.39M-18.99M-18.75M-19.30M-18.46M-22.43M-27.43M-30.14M-25.97M-11.63M27.49M-13.26M-11.91M-3.19M55.11M-12.65M-17.86M-17.70M-20.41M-13.87M-1.70M-7.38M
Preferred Dividend Payments 0.92M0.92M1.24M2.02M2.05M0.83M
Net Income towards Common Stockholders -7.41M-8.33M-7.13M-12.12M-12.08M-14.77M-10.64M-9.96M-10.46M-10.60M-5.46M-13.29M-17.58M-25.56M-22.58M-18.39M-18.99M-18.75M-19.30M-18.46M-22.43M-27.43M-30.14M-25.97M-11.63M27.49M-13.26M-11.91M-3.19M55.11M-12.65M-17.86M-17.70M-20.41M-13.87M-1.70M-7.38M
Additional items
EPS (Basic) -23.23-26.69-21.60-36.21-36.02-1.59-0.74-0.69-0.60-0.60-0.29-0.74-0.95-1.41-1.22-0.85-0.86-0.61-0.66-0.63-0.70-0.92-1.01-0.87-0.330.73-0.25-0.23-0.060.97-0.24-0.33-0.32-0.38-0.25-0.03-0.13
EPS (Weighted Average and Diluted) -0.63-0.70-0.92-1.01-0.87-0.330.73-0.25-0.23-0.060.97-0.24-0.33-0.32-0.38-0.25-0.03-0.13
Shares Outstanding (Weighted Average) 0.32M0.31M0.33M0.33M0.34M9.27M14.37M14.38M17.47M17.74M17.22M17.67M18.66M18.16M19.56M20.63M21.93M22.39M29.41M29.68M32.13M30.90M32.61M32.98M35.88M37.59M52.53M52.57M52.71M52.70M53.52M53.96M54.12M54.04M55.38M56.03M56.28M
Shares Outstanding (Diluted Average) 29.68M32.13M30.90M32.61M32.98M35.88M37.59M52.53M52.57M52.71M52.99M53.52M53.96M54.12M54.04M55.38M56.03M56.28M
EBITDA -7.91M-8.81M-6.41M-9.76M-9.84M-13.87M-10.67M-9.94M-10.47M-10.60M-5.04M-13.14M-17.70M-24.99M-23.29M-17.47M-18.95M-18.59M-19.42M-18.57M22.52M-29.24M-32.83M-28.68M-11.68M26.77M-13.27M-11.91M-3.21M51.19M-13.98M-19.06M-18.59M-21.73M-14.73M-2.44M-7.92M
Tax Rate -224.70%0.70%-1.67%1.40%